logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Chinese Medicine Geun Sin-B (02509.HK) spent about 45,200 Hong Kong dollars on July 9th to repurchase 3000 shares.

date
09/07/2026
The Chit Fung Financial APP reported that Quantex Biological-B (02509.HK) announced on July 9, 2026 that the company will spend approximately HK$45,200 to repurchase 3,000 shares at a repurchase price of HK$15.08 per share.
Latest
1 m ago
Dongyue Group (00189.HK) announces profit growth, with shareholders' net profit expected to increase by over 31% year-on-year in the first half of the year.
2 m ago
Dan Bin: The listing of Changxin and Hailishi is a major positive development, and the A-share market has the ability to produce a trillion-dollar leader in hard technology.
2 m ago
The merger wave in the UK continues! Barclays plans to sell $875 million in debt to help Blackstone's acquisition of aerospace component manufacturer Senior.
3 m ago
By 2029, the three-tier elderly care service network in urban and rural areas of our country will be basically completed.
3 m ago
Gansu Energy (000791.SZ) issued a profit forecast, expected to achieve a net profit attributable to shareholders of 825 million to 845 million yuan in the first half of the year, flat year-on-year.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.